New study: can a multiple sclerosis drug protect nerves?
NCT ID NCT07353216
First seen Jan 28, 2026 · Last updated May 19, 2026 · Updated 16 times
Summary
This study looks at whether the drug ofatumumab can reduce nerve damage in people with relapsing multiple sclerosis (RMS). Researchers will measure a blood marker called sNfL, which indicates nerve injury. About 80 adults with RMS will receive ofatumumab and be followed in a real-world setting. The goal is to see if the drug lowers sNfL levels and is safe for Chinese patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.